[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Stockstudy8 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2744326717.png) Ravi Prasad (RSP) [@Stockstudy8](/creator/twitter/Stockstudy8) on x 79.7K followers
Created: 2025-05-02 04:48:37 UTC

Not a Buy Sell Recommendation : Only Info

News : Zydus Lifesciences: received US FDA approval to manufacture Niacin Extended-Release Tablets for cholesterol management, with annual sales in the US of $XXX million.

Technically trading below 200sma
best valuezone 655-685 zone
upside resistance 913-33 lvl
avoid at cmp

#chartAnalysis #StockMarketIndia

![](https://pbs.twimg.com/media/Gp6xie4aIAEGd97.jpg)

XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1918165708430819664/c:line.svg)

**Related Topics**
[lvl](/topic/lvl)
[$zyduslifebo](/topic/$zyduslifebo)
[not a](/topic/not-a)

[Post Link](https://x.com/Stockstudy8/status/1918165708430819664)